USFDA Archives - Express Pharma

Biocon receives EIR with VAI status

Lupin gains tentative USFDA nod for Sitagliptin and Metformin Hydrochloride Tablets

BridgeBio’s drug for ATTR-CM gains US FDA approval

Alembic Pharma gets form 483 with five procedural observations by USFDA

Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg

Cipla’s manufacturing facility in Goa gets VAI classification

Biocon Biologics’ Bengaluru unit gets VAI classification by US FDA

Zydus gains final USFDA approval for Fludrocortisone Acetate Tablets USP, 0.1 mg

Accord BioPharma’s Biosimilar IMULDOSA gains USFDA approval for treatment of chronic inflammatory conditions

Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg